Quest Diagnostics Inc(DGX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 6:00 PM ET (Korea 10/31 07:00)
Full metrics table
| Index | S&P 500 | P/E | 25.07 | EPS (ttm) | 10.04 | Insider Own | 0.48% | Shs Outstand | 110.0M | Perf Week | 4.11% |
| Market Cap | 27.70B | Forward P/E | 21.02 | EPS next Y | 5.93% | Insider Trans | -9.22% | Shs Float | 109.5M | Perf Month | 8.97% |
| Enterprise Value | 33.59B | PEG | 2.13 | EPS next Q | 2.68 | Inst Own | 97.93% | Short Float | 3.26% | Perf Quarter | 8.57% |
| Income | 1.13B | P/S | 2.34 | EPS this Y | 14.79% | Inst Trans | 0.61% | Short Ratio | 3.6 | Perf Half Y | 30.7% |
| Sales | 11.84B | P/B | 3.63 | EPS next 5Y | 9.85% | ROA | 6.73% | Short Interest | 3.57M | Perf YTD | 45.12% |
| Book/sh | 69.38 | P/C | 34.76 | EPS past 3/5Y | 3.08% -3.64% | ROE | 15.11% | 52W High | -0.51% ($253.12) | Perf Year | 43.28% |
| Cash/sh | 7.24 | P/FCF | 20.15 | Sales past 3/5Y | 3.74% 3.18% | ROIC | 8.2% | 52W Low | 47.11% ($171.18) | Perf 3Y | 94.59% |
| Dividend Est. | $3.34 (1.33%) | EV/EBITDA | 14.4 | EPS Y/Y TTM | 17.93% | Gross Margin | 31.91% | Volatility(W/M) | 2.3% 2.59% | Perf 5Y | 71.56% |
| Dividend TTM | 3.38 | EV/Sales | 2.84 | Sales Y/Y TTM | 9.13% | Oper. Margin | 14.76% | ATR (14) | 6.36 | Perf 10Y | 213.05% |
| Dividend Ex-Date | 2026/10/6 | Quick Ratio | 1.58 | EPS Q/Q | 28.72% | Profit Margin | 9.5% | RSI (14) | 68.33 | Recom | 2.15 |
| Dividend Gr. 3/5Y | 6.62% 7.39% | Current Ratio | 1.7 | Sales Q/Q | 9.98% | SMA20 | 5.98% ($237.61) | Beta | 0.56 | Target Price | $258.29 |
| Payout | 36.6% | Debt/Eq | 0.82 | Earnings | 2026/10/22 | SMA50 | 5.57% ($238.53) | Rel Volume | 0.93 | Prev Close | $252.92 |
| Employees | 57000 | LT Debt/Eq | 0.8 | EPS/Sales Surpr. | 4.35% 1.47% | SMA200 | 18.7% ($212.15) | Avg Volume(3M) | 0.99M | Price | $251.82 |
| IPO | 1996/12/17 | Option/Short | Yes/Yes | Trades | 13588 | Volume | 919,987 | Change | -0.43% |
🔬 Quest Diagnostics (DGX) is a leading medical diagnostics company that reliably delivers comprehensive, high-quality clinical diagnostic information services and advanced precision testing solutions for early disease detection to a large number of patients and major healthcare institutions across the United States.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded about as much as usual. That is 93% of its average volume.
DGX makes money exceptionally well
Of every $100 in sales, $14.76 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.8% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $2,507. Peers typically go for $3,649. Compared with its own 5-year average, it is 25% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +71.6%. The S&P 500 did +65% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.33% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 97.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #11 of 44 in the industry
Based on market cap of $28B.
ILMN#8 Illumina Inc $36B PER 40.5 
MTD#9 Mettler-Toledo International Inc $34B PER 37.7 
LH#10 Labcorp Holdings Inc $29B PER 29.6 
DGX#11 Quest Diagnostics Inc $28B PER 25.1 
GH#12 Guardant Health Inc $24B PER - 
FAQ
What kind of company is DGX?
DGX belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of DGX?
The market cap of DGX is approximately $27.7B, ranking 492 within its sector.
Does DGX pay dividends?
DGX has a dividend yield of approximately 1.33%, with an annual dividend of $3.34.
What is the P/E ratio of DGX?
DGX has a P/E ratio of approximately 25.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DGX?
DGX has recorded a 52-week high of $253.12 and a low of $171.18.
